Key Financial Figures (Standalone, in ₹ millions)

Income Statement for Quarter Ended June 30, 2026:

  • Revenue from Operations: ₹2,480.99 (vs. ₹2,100.90 in Q1 FY2026)
  • Other Income: ₹51.13
  • Total Income: ₹2,532.12
  • Cost of Materials Consumed: ₹1,687.41
  • Changes in Inventories: (₹160.12)
  • Employee Benefit Expenses: ₹444.34
  • Finance Cost: ₹16.50
  • Depreciation & Amortization: ₹72.06
  • Other Expenses: ₹242.57
  • Total Expenses: ₹2,302.76
  • Profit Before Tax: ₹229.36 (vs. ₹232.58 in Q1 FY2026)
  • Total Tax Expense: ₹52.83 (Current Tax: ₹63.54; Deferred Tax: (₹10.71))
  • Profit for the Period: ₹176.53 (vs. ₹176.65 in Q1 FY2026)
  • Other Comprehensive Income: (₹0.46)
  • Total Comprehensive Income: ₹176.07

Earnings Per Share (EPS):

  • Basic EPS: ₹8.46 (vs. ₹8.43 in Q1 FY2026)
  • Diluted EPS: ₹8.32 (vs. ₹8.34 in Q1 FY2026)
  • Face Value per Share: ₹5.00

Capital and Reserves:

  • Paid-up Equity Share Capital: ₹103.18 million
  • Total Reserves: Not stated for the quarter

Corporate Actions and Capital Structure

Share Buyback:

Pursuant to a Board Resolution dated April 17, 2026, the company completed a buyback of 470,000 fully paid-up equity shares via a Tender Offer at a price of ₹1,000 per share, aggregating ₹470 million. Consequently, the issued, subscribed, and paid-up equity share capital was reduced to 20,636,229 equity shares of ₹5 face value each. A Capital Redemption Reserve of ₹2.35 million was created.

Dividend:

The Board of Directors proposed a dividend of ₹6.30 per share for FY2026 at a meeting on May 21, 2026. Shareholders approved this in the Annual General Meeting held on July 23, 2026. An aggregate dividend payout of ₹130.01 million was made on July 31, 2026.

Employee Stock Options:

On May 21, 2026, the company granted 21,250 units under the WBL Plan 2025 at an exercise price of ₹5 per unit and 14,125 options under the ESOS Scheme 2023 at ₹600 per option. An employee share-based payment expense of ₹71.62 million was recognized for the quarter. In the previous year, 146,918 equity shares were allotted to employees, increasing the issued share capital from ₹104.80 million to ₹105.53 million.

Subsidiary Update

Pursuant to a Board Resolution dated February 5, 2026, and a filing with the Delaware Division of Corporations, the company's wholly-owned non-operating US subsidiary, Windlas Inc., was dissolved effective March 31, 2026. Consequently, the company is no longer required to prepare consolidated financial statements from April 1, 2026.

Other Matters

The financial results were reviewed by the Audit Committee and Statutory Auditors, J. C. Bhalla & Co., who issued an unmodified limited review report. The company operates in a single reportable segment: Pharmaceuticals. The impact of new Indian labour codes effective November 21, 2025, was assessed as not material for FY2026.